The Carbon Trust has invested in a novel, low-cost fuel cell architecture which is being commercialised by UCLB and Imperial Innovations. Published on Monday 20 February 2012
The Carbon Trust is injecting over half a million pounds into a collaboration between UCL and Imperial College to accelerate the commercialisation of an innovative fuel cell. The new technology could help the UK gain a significant share of a fuel cell market estimated by the Carbon... more
UCL spinout company, Abcodia collaborates with Volition Rx to advance the discovery of blood based biomarkers for cancer Published on Friday 17 February 2012
Abcodia, a biomarker validation company and a UCL spin out company, with investment from UCLB, has today announced a collaboration with life sciences company Volition Rx which will advance the development of biomarkers for the early detection of cancer. The partnership will discover... more
UCLB patented technology used to develop a potential new treatment for Corneal Surface Disease Published on Tuesday 14 February 2012
Researchers at UCL have made a significant advance towards developing a treatment for Corneal Surface Disease, using RAFTTM; a UCLB patented technology licensed to Tap Biosystems. The development was led by Professor Robert Brown at UCL's Tissue Repair and Engineering Centre (TREC)... more
UCLB supports venture capital firm MTI to target new investment fund Published on Thursday 9 February 2012
The Orion fund is being launched in a partnership between UCLB, MTI and the technology transfer offices of the Universities of Manchester and Edinburgh. UCLB will work alongside UMI3 of the University of Manchester and ERI from the University of Edinburgh to identify investment... more
A team of budding student entrepreneurs have won a £500 cash prize, provided by UCLB, in the UCL Apprentice Challenge 2012. Published on Thursday 26 January 2012
The competition, hosted by Ernst & Young at its London headquarters, saw the eight teams of students selected by the UCL Entrepreneurs Society battling it out in a series of challenges to be crowned ultimate victor. The day saw the teams in a frantic dash around London completing... more
Pentraxin Therapeutics founder is awarded a knighthood Published on Thursday 5 January 2012
UCLB 2011 Award winner, Professor Sir Mark Pepys was knighted for services to Biomedicine in this year's New Years Honour 2012 list. Professor Pepys is the founder of Pentraxin Therapeutics Ltd, a UCL spinout company which focuses on the treatment of amyloidosis and the Director of the... more
UCL spinout company, Endomagnetics Ltd, has been shortlisted for the ACES final in 2012 Published on Tuesday 20 December 2011
The ACES (Academic Enterprise Awards) programme, formed to promote innovation in Europe, is holding its fourth annual awards final in Brussels next year. Selected as one of three finalists in the Life Sciences award category, Endomagnetics Ltd is to participate in the two day "Start up! The... more
Gene therapy treatment of haemophilia Published on Friday 16 December 2011
The recent publication by UCL (Professor Amit Nathwani), St Judes Children’s hospital and the Royal Free Hospital in the New England Journal of Medicine describes how a single infusion of this Factor IX treatment consistently leads to long-term expression of the missing protein. This missing... more
UCLB's Consultant Entrepreneur Finishes Top 30 in Global Entrepreneurship Competition Published on Friday 9 December 2011
  Chester Mojay-Sinclare, UCLB's consultant entrepreneur and CEO of CharityCheckout.co.uk, participated in the 2011 Global Student Entrepreneurship Awards in New York, last month. Chester's participation in NACUE's National Varsity Pitch earlier this year, earned him a... more
UCLB Agrees Exclusive Licence Deal With The Linde Group Published on Tuesday 15 November 2011
UCLB has agreed an exclusive licence with the world-leading gases and engineering company The Linde Group for a process to separate and purify single-wall nanotubes. Single-wall carbon nanotubes (SWNTs) offer excellent electronic and mechanical properties, making them suitable for a vast range of... more